Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
复制标题
DOI:
10.1007/s11904-020-00508-z
复制
发表时间:
2020-08
影响因子:
4.6
通讯作者:
Lo Re V 3rd
中科院分区:
文献类型:
--
作者:
Ferrante ND;Lo Re V 3rd
Limited data exist on the prevalence, determinants, and outcomes of hepatitis delta virus (HDV) infection among HIV/hepatitis B virus (HBV)-coinfected persons. This review provides current evidence on the epidemiology, natural history, and treatment of HDV infection in patients with HIV/HBV coinfection and highlights future research needs. Cross-sectional studies in Europe, Africa, South America, and Asia show that the prevalence of HDV among HIV/HBV-coinfected patients ranges from 1.2%–25%. No studies have evaluated the prevalence of HDV infection among HIV/HBV-coinfected patients in the United States. HDV infection increases the risk of hepatic decompensation and hepatocellular carcinoma among HIV/HBV-coinfected patients. HDV treatment remains limited to pegylated interferon-alpha, which results in sustained virologic response in <25%. Data on the epidemiology, natural history, and treatment of HDV among HIV/HBV-coinfected persons remain limited. More research is needed to address these knowledge gaps in order to better manage HDV coinfection in HIV/HBV-coinfected patients.
登录
查看更多内容
影响因子:
25.7
作者:
Beguelin, Charles;Moradpour, Darius;Wandeler, Gilles
通讯作者:
Wandeler, Gilles
影响因子:
35.7
作者:
Bazinet, Michel;Pantea, Victor;Vaillant, Andrew
通讯作者:
Vaillant, Andrew
影响因子:
1.2
作者:
Abbas, Zaigham;Memon, Mohammad S.;Hamid, Saeed
通讯作者:
Hamid, Saeed
影响因子:
1.5
作者:
Boyd, Anders;Miailhes, Patrick;Lacombe, Karine
通讯作者:
Lacombe, Karine
影响因子:
6.7
作者:
Erhardt, Andreas;Gerlich, Wolfram;Haeussinger, Dieter
通讯作者:
Haeussinger, Dieter